Last Update 17 May 26
ACKB: Future Returns Will Reflect Updated Risk Profile And P E Assumptions
Analysts have raised their price target on Ackermans & Van Haaren to €330 from €289, citing updated views on the stock's risk profile, earnings outlook and P/E assumptions.
Analyst Commentary
Bullish Takeaways
- Bullish analysts see the move to a €330 price target as better aligning the stock with their updated P/E assumptions, suggesting the current valuation may not fully reflect their earnings expectations.
- The higher target is tied to refreshed views on the company’s risk profile, which these analysts now regard as more comfortable relative to their prior framework.
- They point to earnings outlook adjustments as a key driver behind the revised target, indicating that their models now factor in a more supportive earnings setup than before.
- The combination of a higher target and maintained positive stance is framed as a signal that, in their view, execution has tracked closely enough with expectations to justify a richer valuation multiple.
Bearish Takeaways
- More cautious analysts may question whether the updated P/E assumptions leave enough room for disappointment if earnings do not match the refreshed outlook.
- The reliance on a refined risk profile could be seen as vulnerable if any new company specific or macro shocks emerge that are not fully captured in current models.
- Some may argue that a higher target tightens the margin of safety for new investors, especially if execution slips against the expectations embedded in the revised valuation.
- There is also the risk that sentiment has become more optimistic than the available earnings visibility justifies, which could limit upside if future updates are more muted than analysts currently factor in.
Valuation Changes
- Fair Value: remains at €296.29, indicating no adjustment to the modelled intrinsic value per share.
- Discount Rate: has risen slightly from 8.59% to 9.15%, pointing to a somewhat higher required return in the valuation model.
- Revenue Growth: remains effectively unchanged at about 2.80%, with only an immaterial rounding difference between the old and new assumptions.
- Net Profit Margin: remains effectively unchanged at about 10.30%, with the revision reflecting only a minor technical adjustment.
- Future P/E: has risen slightly from 18.20x to 18.49x, suggesting a modestly higher multiple applied to expected earnings in the updated model.
2 viewsusers have viewed this narrative update
Key Takeaways
- Strong growth and collaboration in financial services suggest sustained revenue increases and enhanced banking operations.
- Strategic investments and financial flexibility position for diversified revenue streams and potential earnings growth.
- Heavy reliance on specific subsidiaries poses concentration risk, while external growth and new investments carry execution and integration challenges, impacting future financial performance.
Catalysts
About Ackermans & Van Haaren- Engages in marine engineering and contracting, private banking, real estate and senior care, energy and resources, and AvH & Growth Capital businesses worldwide.
- The strong growth and record results achieved by Delen Private Bank and Bank Van Breda, with net inflows and synergetic collaboration, signal continued future revenue growth from financial services.
- DEME's record turnover and solid free cash flow generation, paired with reduced net financial debt, set the stage for improved net margins and earnings from enhanced operational efficiency and financial flexibility.
- The renewed and extended partnership with the Delen family indicates strengthened client relationships and potential for future revenue increases and net margin improvements in banking operations.
- Strategic investments, such as those in V. Group and Confo Therapeutics, point towards diversified future revenue streams and potential earnings growth from these sectors.
- The current net cash position of €362 million provides opportunities for further investments, likely leading to future revenue growth and potentially higher earnings through strategic acquisitions and financial growth initiatives.
Ackermans & Van Haaren Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Ackermans & Van Haaren's revenue will grow by 2.8% annually over the next 3 years.
- Analysts assume that profit margins will increase from 9.9% today to 10.3% in 3 years time.
- Analysts expect earnings to reach €667.0 million (and earnings per share of €20.27) by about May 2029, up from €592.5 million today. The analysts are largely in agreement about this estimate.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 18.7x on those 2029 earnings, up from 15.5x today. This future PE is greater than the current PE for the GB Construction industry at 14.4x.
- Analysts expect the number of shares outstanding to decline by 0.25% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 9.15%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Heavy reliance on specific subsidiaries like Delen Private Bank, Bank Van Breda, and DEME for growth could pose a concentration risk, potentially impacting revenue and earnings if these entities face downturns.
- Recent investments in new sectors and companies, such as V. Group and Confo Therapeutics, may encounter integration challenges or fail to achieve expected returns, impacting net margins.
- Continued investments, despite strong free cash flow, require efficient capital allocation; missteps could strain financial resources, affecting future earnings and profitability.
- While current cash positions are strong, economic downturns or unexpected market challenges could deplete cash reserves, impacting the company's ability to invest and sustain growth.
- External growth initiatives, though promising, carry execution risks, and any failure in execution might hinder expected revenue growth, impacting overall financial performance.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of €296.29 for Ackermans & Van Haaren based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €340.0, and the most bearish reporting a price target of just €245.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €6.5 billion, earnings will come to €667.0 million, and it would be trading on a PE ratio of 18.7x, assuming you use a discount rate of 9.2%.
- Given the current share price of €281.6, the analyst price target of €296.29 is 5.0% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Ackermans & Van Haaren?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Read more narratives
There are no other narratives for this company.
View all narratives